Skip to content
Home/Companies/HealthTech/Candid (Exit)
Candid (Exit)

Candid (Exit)

HealthTech·USA·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Candid (Exit)?

Candid (Exit) is an American HealthTech company, currently owned by Blisce since 2018.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Blisce
Investor
Blisce
Blisce Deal-by-Deal · 2014 · Growth

Key facts

HQUSA
SectorHealthTech
Websitewww.candidpro.com

More from Blisce Deal-by-Deal

Other portfolio companies in the same fund.

Lokki
Active
HospitalityFrance· 2019
Bird
Exited 2021
MobilityUS· 2018
to NYSE (BRDS)
Stadium Goods
Exited 2018
ConsumerUS· 2017
to Farfetch
Wecasa
Wecasa
Active
ConsumerFrance· 2016
Harry's
Harry's
Active
ConsumerUS· 2015
Teads
Teads
Exited 2017
TMTFrance· 2015
to Altice

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Candid (Exit)?

Candid (Exit) is currently owned by Blisce, through Blisce Deal-by-Deal, since 2018.

When did Blisce acquire Candid (Exit)?

Blisce acquired Candid (Exit) in 2018.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue